ArticleGastroenterology report2022

Evaluating the safety and efficacy of mesenchymal stem cell-derived exosomes for treatment of refractory perianal fistula in IBD patients: clinical trial phase I.

Hojjatollah Nazari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.